Catalyst Pharmaceuticals Inc (CPRX)

Gross profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Gross profit	US$ in thousands	179,962	120,529	69,321	57,800	50,666
Revenue	US$ in thousands	398,204	214,203	140,833	119,073	102,306
Gross profit margin		45.19%	56.27%	49.22%	48.54%	49.52%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $179,962K ÷ $398,204K
= 45.19%

Catalyst Pharmaceuticals Inc's gross profit margin has exhibited some fluctuations in recent years. The gross profit margin decreased from 56.27% in 2022 to 45.19% in 2023, indicating a decline in the percentage of revenue retained after accounting for the cost of goods sold. Despite this decrease, the company's gross profit margin in 2023 remains within a reasonable range compared to previous years, such as the margins of 49.22% in 2021, 48.54% in 2020, and 49.52% in 2019. This suggests that Catalyst Pharmaceuticals Inc has been able to effectively manage its production costs relative to its revenue, although there may be room for improvement in optimizing cost structures to enhance profitability. It is important for the company to closely monitor its gross profit margin trends and take strategic actions to maintain or improve profitability levels over time.